Oral cancer cases are on the rise across the globe. Oral cancer, affecting the mouth, lips, tongue, or throat, claims ...

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2 ...

The US-based biotech company has submitted an application to the Saudi Food and Drug Authority (SFDA) for Breakthrough ...

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two rare types of adrenal gland tumors.

While cavities themselves don’t directly cause cancer, the connections ... new blood vessels that feed tumors). The relationship appears bidirectional—poor oral health can contribute to ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains ...

Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune ...

ASCO Data Shows New Therapy Delays Breast Cancer Progression and May Improve Quality of Life for Women with Hormone ...